Global High Throughput Screening (HTS) Service Market Growth Forecast Report 2025-2031
On Nov 27, the latest report "Global High Throughput Screening (HTS) Service Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global High Throughput Screening (HTS) Service market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2025.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3383791/high-throughput-screening--hts--service
According to our (Global Info Research) latest study, the global High Throughput Screening (HTS) Service market size was valued at US$ 354 million in 2025 and is forecast to a readjusted size of USD million by 2032 with a CAGR of % during review period.
HTS is an automated experimental technology that processes thousands to millions of samples (e.g., chemical compounds, biological molecules, cells) in parallel within a short time. It aims to efficiently identify active substances or interactions that meet specific research goals.
To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The global market for high-throughput screening (HTS) services is poised for substantial growth driven by several key factors. The increasing prevalence of chronic diseases, rising demand for personalized medicine, and the expanding drug discovery and development activities are primary drivers fueling the market's expansion. Additionally, advancements in automation technologies, such as robotics and artificial intelligence, are enhancing the efficiency and accuracy of HTS processes, further propelling market growth.
Furthermore, the pharmaceutical and biotechnology sectors are anticipated to remain the dominant end-users of HTS services, given their continuous efforts to expedite drug discovery pipelines and reduce time-to-market for novel therapeutics. Moreover, the adoption of HTS services by academic research institutions and contract research organizations (CROs) is expected to surge, driven by the need for cost-effective and rapid screening solutions.
Geographically, North America is projected to maintain its leadership position in the HTS services market, attributed to the presence of a robust pharmaceutical industry, significant research funding, and a favorable regulatory environment. However, emerging economies in Asia-Pacific, such as China and India, are witnessing rapid growth in HTS adoption due to increasing investments in healthcare infrastructure and research activities.
Despite the promising outlook, challenges such as high initial setup costs, ethical concerns related to the use of animal models, and regulatory complexities may hinder market growth to some extent. Nonetheless, collaborations between industry players, academic institutions, and government bodies, along with continuous technological innovations, are anticipated to mitigate these challenges and drive the market forward.
In summary, the global market for high-throughput screening services is anticipated to witness substantial growth in the coming years, driven by increasing research and development activities, technological advancements, and growing demand for efficient drug discovery solutions. Stakeholders across the pharmaceutical, biotechnology, academic, and CRO sectors are poised to benefit from the expanding opportunities in this dynamic market landscape.
This report is a detailed and comprehensive analysis for global High Throughput Screening (HTS) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
High Throughput Screening (HTS) Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Chemical-based HTS Service、 Biological-based HTS Service、 Cell-based HTS Service、 Genetic-based HTS Service
Market segment by Application: Pharmaceutical Industry、 Universities and Scientific Research Institutions
Major players covered: Eurofins Discovery、 Charles River Laboratories、 Axcelead、 NUVISAN、 Axxam S.p.A.、 Evotec、 Selvita、 Azenta Life Sciences、 Bienta (Enamine)、 Cayman Chemical、 Creative Biolabs、 Creative Bioarray、 BOC Sciences、 MEDICILON、 Domainex、 Creative Diagnostics、 Multispan、 AntalGenics、 Creative Biostructure、 BPS Bioscience
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Throughput Screening (HTS) Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High Throughput Screening (HTS) Service, with price, sales quantity, revenue, and global market share of High Throughput Screening (HTS) Service from 2020 to 2025.
Chapter 3, the High Throughput Screening (HTS) Service competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Throughput Screening (HTS) Service breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment High Throughput Screening (HTS) Service the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the High Throughput Screening (HTS) Service sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and High Throughput Screening (HTS) Service market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High Throughput Screening (HTS) Service.
Chapter 14 and 15, to describe High Throughput Screening (HTS) Service sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Throughput Screening (HTS) Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3383791/high-throughput-screening--hts--service
According to our (Global Info Research) latest study, the global High Throughput Screening (HTS) Service market size was valued at US$ 354 million in 2025 and is forecast to a readjusted size of USD million by 2032 with a CAGR of % during review period.
HTS is an automated experimental technology that processes thousands to millions of samples (e.g., chemical compounds, biological molecules, cells) in parallel within a short time. It aims to efficiently identify active substances or interactions that meet specific research goals.
To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The global market for high-throughput screening (HTS) services is poised for substantial growth driven by several key factors. The increasing prevalence of chronic diseases, rising demand for personalized medicine, and the expanding drug discovery and development activities are primary drivers fueling the market's expansion. Additionally, advancements in automation technologies, such as robotics and artificial intelligence, are enhancing the efficiency and accuracy of HTS processes, further propelling market growth.
Furthermore, the pharmaceutical and biotechnology sectors are anticipated to remain the dominant end-users of HTS services, given their continuous efforts to expedite drug discovery pipelines and reduce time-to-market for novel therapeutics. Moreover, the adoption of HTS services by academic research institutions and contract research organizations (CROs) is expected to surge, driven by the need for cost-effective and rapid screening solutions.
Geographically, North America is projected to maintain its leadership position in the HTS services market, attributed to the presence of a robust pharmaceutical industry, significant research funding, and a favorable regulatory environment. However, emerging economies in Asia-Pacific, such as China and India, are witnessing rapid growth in HTS adoption due to increasing investments in healthcare infrastructure and research activities.
Despite the promising outlook, challenges such as high initial setup costs, ethical concerns related to the use of animal models, and regulatory complexities may hinder market growth to some extent. Nonetheless, collaborations between industry players, academic institutions, and government bodies, along with continuous technological innovations, are anticipated to mitigate these challenges and drive the market forward.
In summary, the global market for high-throughput screening services is anticipated to witness substantial growth in the coming years, driven by increasing research and development activities, technological advancements, and growing demand for efficient drug discovery solutions. Stakeholders across the pharmaceutical, biotechnology, academic, and CRO sectors are poised to benefit from the expanding opportunities in this dynamic market landscape.
This report is a detailed and comprehensive analysis for global High Throughput Screening (HTS) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
High Throughput Screening (HTS) Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Chemical-based HTS Service、 Biological-based HTS Service、 Cell-based HTS Service、 Genetic-based HTS Service
Market segment by Application: Pharmaceutical Industry、 Universities and Scientific Research Institutions
Major players covered: Eurofins Discovery、 Charles River Laboratories、 Axcelead、 NUVISAN、 Axxam S.p.A.、 Evotec、 Selvita、 Azenta Life Sciences、 Bienta (Enamine)、 Cayman Chemical、 Creative Biolabs、 Creative Bioarray、 BOC Sciences、 MEDICILON、 Domainex、 Creative Diagnostics、 Multispan、 AntalGenics、 Creative Biostructure、 BPS Bioscience
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Throughput Screening (HTS) Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High Throughput Screening (HTS) Service, with price, sales quantity, revenue, and global market share of High Throughput Screening (HTS) Service from 2020 to 2025.
Chapter 3, the High Throughput Screening (HTS) Service competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Throughput Screening (HTS) Service breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment High Throughput Screening (HTS) Service the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the High Throughput Screening (HTS) Service sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and High Throughput Screening (HTS) Service market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High Throughput Screening (HTS) Service.
Chapter 14 and 15, to describe High Throughput Screening (HTS) Service sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Throughput Screening (HTS) Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
